Westaim
Founded in 1996, Westaim is a publicly traded investment holding company based in New York. It specializes in providing long-term capital to businesses operating primarily within the global financial services industry. The company focuses on partnering with high-quality investments and aligned management teams to generate above-average returns for shareholders over the long term.
Top Regions
Top Stages
1 past transactions
NUCRYST Pharmaceuticals
Acquisition in 2009
NUCRYST Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation using SILCRYST(TM), its patented atomically disordered nanocrystalline silver technology. NUCRYST licensed world-wide rights for SILCRYST(TM) wound care coating products to Smith & Nephew plc, which markets these products in over 30 countries under their Acticoat(TM) trademark. NUCRYST has developed its proprietary nanocrystalline silver in a powder form, referred to as NPI 32101, for use in medical devices and as an active pharmaceutical ingredient.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.